Cutter & CO Brokerage, Inc. Novo Nordisk A S Transaction History

Cutter & CO Brokerage, Inc.

  • $406 Million
  • Q3 2024

A detailed history of Cutter & CO Brokerage, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Cutter & CO Brokerage, Inc. holds 281,795 shares of NVO stock, worth $24.2 Million. This represents 8.26% of its overall portfolio holdings.

Number of Shares
281,795
Previous 284,178 0.84%
Holding current value
$24.2 Million
Previous $40.6 Million 17.28%
% of portfolio
8.26%
Previous 10.7%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$119.07 - $145.42 $283,743 - $346,535
-2,383 Reduced 0.84%
281,795 $33.6 Million
Q2 2024

Jul 31, 2024
SELL
$122.71 - $146.91 $381,382 - $456,596
-3,108 Reduced 1.08%
284,178 $40.6 Million
Q1 2024

Apr 30, 2024
SELL
$102.11 - $135.92 $392,306 - $522,204
-3,842 Reduced 1.32%
287,286 $36.9 Million
Q4 2023

Feb 01, 2024
SELL
$87.78 - $105.45 $69,170 - $83,094
-788 Reduced 0.27%
291,128 $30.1 Million
Q3 2023

Oct 31, 2023
BUY
$90.94 - $199.54 $13.7 Million - $30.1 Million
150,877 Added 106.98%
291,916 $26.5 Million
Q2 2023

Aug 01, 2023
BUY
$155.98 - $172.65 $779,744 - $863,077
4,999 Added 3.67%
141,039 $22.8 Million
Q1 2023

May 09, 2023
BUY
$132.34 - $159.14 $129,693 - $155,957
980 Added 0.73%
136,040 $21.6 Million
Q4 2022

Feb 03, 2023
BUY
$102.55 - $135.33 $9.12 Million - $12 Million
88,976 Added 193.07%
135,060 $18.3 Million
Q3 2022

Nov 03, 2022
SELL
$95.28 - $116.93 $3,239 - $3,975
-34 Reduced 0.07%
46,084 $4.59 Million
Q2 2022

Jul 28, 2022
BUY
$103.24 - $121.81 $619 - $730
6 Added 0.01%
46,118 $5.14 Million
Q1 2022

May 03, 2022
SELL
$93.1 - $112.54 $12,940 - $15,643
-139 Reduced 0.3%
46,112 $5.12 Million
Q4 2021

Feb 10, 2022
BUY
$95.88 - $117.08 $31,832 - $38,870
332 Added 0.72%
46,251 $5.18 Million
Q3 2021

Nov 02, 2021
SELL
$84.42 - $106.62 $67,282 - $84,976
-797 Reduced 1.71%
45,919 $4.41 Million
Q2 2021

Aug 09, 2021
SELL
$67.66 - $84.76 $6,833 - $8,560
-101 Reduced 0.22%
46,716 $3.91 Million
Q1 2021

May 11, 2021
SELL
$67.06 - $75.82 $23,806 - $26,916
-355 Reduced 0.75%
46,817 $3.16 Million
Q4 2020

Feb 03, 2021
SELL
$63.89 - $73.8 $118,452 - $136,825
-1,854 Reduced 3.78%
47,172 $3.3 Million
Q3 2020

Nov 05, 2020
SELL
$63.69 - $70.22 $79,421 - $87,564
-1,247 Reduced 2.48%
49,026 $3.4 Million
Q2 2020

Aug 10, 2020
SELL
$58.54 - $67.94 $361,191 - $419,189
-6,170 Reduced 10.93%
50,273 $3.29 Million
Q1 2020

May 05, 2020
SELL
$49.46 - $64.78 $489,901 - $641,645
-9,905 Reduced 14.93%
56,443 $3.4 Million
Q4 2019

Feb 11, 2020
SELL
$49.86 - $58.26 $422,463 - $493,636
-8,473 Reduced 11.32%
66,348 $3.84 Million
Q3 2019

Nov 07, 2019
SELL
$47.54 - $53.43 $798,672 - $897,624
-16,800 Reduced 18.34%
74,821 $3.87 Million
Q2 2019

Jul 31, 2019
SELL
$46.79 - $52.47 $182,574 - $204,737
-3,902 Reduced 4.08%
91,621 $4.68 Million
Q1 2019

Apr 23, 2019
SELL
$46.36 - $52.63 $254,748 - $289,201
-5,495 Reduced 5.44%
95,523 $5 Million
Q4 2018

Feb 07, 2019
SELL
$41.54 - $47.25 $2.13 Million - $2.42 Million
-51,310 Reduced 33.68%
101,018 $4.65 Million
Q3 2018

Oct 12, 2018
SELL
$46.76 - $51.24 $582,582 - $638,399
-12,459 Reduced 7.56%
152,328 $7.18 Million
Q2 2018

Jul 30, 2018
SELL
$44.29 - $50.42 $354,851 - $403,965
-8,012 Reduced 4.64%
164,787 $7.6 Million
Q1 2018

May 11, 2018
BUY
$48.49 - $58.14 $175,921 - $210,931
3,628 Added 2.14%
172,799 $8.51 Million
Q4 2017

Jan 30, 2018
SELL
$47.53 - $53.73 $374,061 - $422,855
-7,870 Reduced 4.45%
169,171 $9.08 Million
Q3 2017

Oct 23, 2017
SELL
$41.15 - $49.22 $258,792 - $309,544
-6,289 Reduced 3.43%
177,041 $8.53 Million
Q2 2017

Aug 07, 2017
BUY
N/A
183,330
183,330 $7.86 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $194B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cutter & CO Brokerage, Inc. Portfolio

Follow Cutter & CO Brokerage, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email